News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Gene fault has domino effect on cancer risk
A team at the ICR have found some cancer patients inherit a weak point in their DNA that appears to leave one of their chromosomes vulnerable to damage.
Scientists unlock hidden potential of cutting-edge cancer drugs
A class of cutting-edge cancer drugs could keep patients alive for much longer than they do now following a major new discovery about exactly how they attack tumours.
Awards for ICR researchers, Maria and Vicky
Vicky Bull, PhD student, was awarded the ‘BMUS Young Investigator's Award’ and Dr Maria Vinci, Post Doc Training Fellow, is nominated for a SET for BRITAIN Award.
A new way to overcome breast cancer drug resistance
Scientists at the ICR have discovered a potential new way to overcome the resistance many women develop towards a treatment for breast cancer.
New insights into molecular mechanism of childhood cancer
A molecule's key role in the development of a childhood cancer has been discovered by scientists at The Institute of Cancer Research, London.
.jpg?sfvrsn=c51c15c8_2 "Professor Kevin Harrington (Jon Enoch for the ICR, 2012)")
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses
Professor Kevin Harrington has just been appointed joint head of the division of radiotherapy and imaging at The Institute of Cancer Research (ICR), London. Here, he talks about the novel approach his department will be taking to traditional radiotherapy treatment.
Gene may explain why some breast cancers are hard to treat
Researchers have identified a gene which some aggressive breast cancers rely on to survive, helping to explain why certain patients fail to benefit from targeted treatment.
Plan for action to fight global cancer unveiled
A 10-point plan to turn back the tide on cancer has been published to mark World Cancer Day. Developed by the World Oncology Forum, including the ICR's Professor Stan Kaye, the plan calls for more focus on research, and for governments around the world to invest in better healthcare systems to help reduce the number of people dying from the disease.
New Tumour Profiling Unit signals push for personalised cancer treatment
A new Tumour Profiling Unit at the ICR will accelerate the development of personalised cancer treatments and their delivery to patients.
Launch of trial of 'master switch' drug to treat several cancer types
Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The early-stage Phase I clinical trial of up to 40 patients will be carried out by the ICR, and The Royal Marsden Hospital.
Key driver of aggressive prostate cancer found
A key driver for aggressive forms of prostate cancer has been uncovered by scientists at The Institute of Cancer Research, London.
'Virtual experiments' aid scientists to find missing cancer targets
Scientists have identified 46 previously overlooked but potentially ‘druggable’ cancer targets, using a powerful new online approach that allows researchers to carry out ‘virtual experiments’ to quickly prioritise which are the best targets for drug discovery.
